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Alzheimer’s disease (AD) is characterized by specific alterations of brain DNA methylation
(DNAm) patterns. Age and sex, two major risk factors for AD, are also known to
largely affect the epigenetic profiles in brain, but their contribution to AD-associated
DNAm changes has been poorly investigated. In this study we considered publicly
available DNAm datasets of four brain regions (temporal, frontal, entorhinal cortex, and
cerebellum) from healthy adult subjects and AD patients, and performed a meta-analysis
to identify sex-, age-, and AD-associated epigenetic profiles. In one of these datasets it
was also possible to distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine
(5hmC) profiles. We showed that DNAm differences between males and females tend
to be shared between the four brain regions, while aging differently affects cortical
regions compared to cerebellum. We found that the proportion of sex-dependent probes
whose methylation is modified also during aging is higher than expected, but that
differences between males and females tend to be maintained, with only a few probes
showing age-by-sex interaction. We did not find significant overlaps between AD- and
sex-associated probes, nor disease-by-sex interaction effects. On the contrary, we
found that AD-related epigenetic modifications are significantly enriched in probes whose
DNAm varies with age and that there is a high concordance between the direction of
changes (hyper or hypo-methylation) in aging and AD, supporting accelerated epigenetic
aging in the disease. In summary, our results suggest that age-associated DNAm
patterns concur to the epigenetic deregulation observed in AD, providing new insights
on how advanced age enables neurodegeneration.
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INTRODUCTION
Alzheimer’s disease (AD) is a chronic neurodegenerative disease
that leads to a progressive decay of cognitive abilities and
self-sufficiency. Neuronal loss involves multiple brain regions
that are progressively affected by the disease. Hippocampus
and entorhinal cortex exhibit the earliest pathological changes,
preceding the onset of clinical signs and cognitive impairment
by several years, and later the disease spreads to the other brain
regions (Braak and Braak, 1991; Van Hoesen et al., 1991; Scahill
et al., 2002; Coupé et al., 2019).
Advanced age and female sex are the two major non-
modifiable risk factors for AD (Hickman et al., 2016; Podcasy
and Epperson, 2016; Fisher et al., 2018). More than 95% of
cases of AD occur after 65 years of age (late onset AD), and
AD prevalence increases exponentially between 65 and 85 years
(Hebert et al., 1995; Kawas and Corrada, 2006). Two-thirds of
clinically diagnosed cases of AD are women, and the fact that
women live longer than man does not fully explain this sex bias
for AD (Pike, 2017; Nebel et al., 2018).
The etiology and pathogenesis of AD are complex and likely
result from the interplay between genetic and environmental
factors during lifespan. In this scenario epigenetic modifications
have attracted increased interest in the study of AD, as
they integrate genetic background and environment and
modulate genomic organization and gene expression. Epigenetic
modifications regulate brain biology throughout development
and lifetime, influencing neuronal plasticity, cognition, and
behavior (Fagiolini et al., 2009), and deregulation of brain
epigenetic patterns has been associated to the pathogenesis of
neurological and psychiatric disorders (Landgrave-Gómez et al.,
2015; Jaffe et al., 2016). Several studies in post-mortem AD brains
have investigated the role of DNA methylation (DNAm), the
best-characterized epigenetic modification, identifying a number
of CpG sites that show robust changes in DNAm compared to
non-demented controls (Lunnon et al., 2014; Gasparoni et al.,
2018; Smith et al., 2018, 2019, 2020; Altuna et al., 2019; Lardenoije
et al., 2019; Semick et al., 2019; Smith R. G. et al., 2020; Wei et al.,
2020).
Interestingly, the two major non-modifiable AD risk factors
mentioned above, i.e., sex and age, are also among the main
biological variables that influence epigenetic patterns in most
human tissues, including brain (Gilbert et al., 2019).
Genome-wide DNAm differences between males and females
have been found in whole blood (Singmann et al., 2015) and
have been related to the sex-biased risk of psychiatric diseases
(Maschietto et al., 2017). A similar link has been reported also
Abbreviations: DNAm, DNA methylation; AD, Alzheimer’s disease; DMPs,
differentially methylated positions; EWAS, epigenome-wide association study;
GO, gene ontology; sDMPs, sex-associated differentially methylated positions;
aDMPs, age-associated differentially methylated positions; s&aDMPs, sex-,
and age-associated differentially methylated positions; AD&aDMPs, late onset
Alzheimer’s disease-specific age-associated differentially methylated positions;
AD&sDMPs, late onset Alzheimer’s disease-specific sex-associated variably
methylated positions; AD&a&sDMPs, late onset Alzheimer’s disease-specific
sex- and age-associated variably methylated positions; 5mC, 5-methylcytosine;
5hmC, 5-hydroxymethylcytosine; 5uC, unmethylated cytosine; BS, bisulfite; oxBS,
oxidative bisulfite.
in brain (Xia et al., 2019) where sex-specific DNAm patterns are
established early during prenatal development (Spiers et al., 2015;
Perzel Mandell et al., 2020) and are at least in part maintained in
the adulthood (Xu et al., 2014; Spiers et al., 2015), contributing to
the profound differences in brain functions between males and
females (McCarthy et al., 2009; Forger, 2016; Gegenhuber and
Tollkuhn, 2019) and to the different onset of psychiatric disorders
(Perzel Mandell et al., 2020).
DNAm patterns are largely remodeled during aging (Pal and
Tyler, 2016), where a trend toward global loss of DNAm together
with hypermethylation at specific loci is observed (Xiao et al.,
2019). Although with some differences among brain regions
(Hernandez et al., 2011; Horvath et al., 2015), age-associated
epigenetic changes interest also the brain, likely contributing
to the structural and functional alterations that can result in
progressive cognitive decline and increased susceptibility to
neurodegenerative disorders (Bishop et al., 2010; Lardenoije
et al., 2015).
So far, only few studies have considered how sex and age
interact during lifespan in shaping the epigenome. Data on
whole blood indicate that sex-dependent DNAm is remodeled
during aging (McCartney et al., 2019), and we suggested that
these changes occur at different extent in human models of
successful and unsuccessful aging (Yusipov et al., 2020). Inmouse
hippocampus and human frontal cortex, Masser et al. identified
both CpGs in which sex-dependent DNAm is maintained during
lifetime, and CpG sites that are differentially affected by aging in
relation to sex (Masser et al., 2017). Interestingly, some studies
employing epigenetic clocks, i.e., DNAm-based predictors of age,
reported accelerated aging in whole blood from males compared
to females (Horvath et al., 2016; Xiao et al., 2018; Tajuddin et al.,
2019), and the same trend was observed also in brain (Horvath
et al., 2016).
Collectively, the available data sustain the importance of sex
and aging in shaping the brain epigenome, but so far only
one study combined different datasets to identify reproducible
sex-associated DNAm profiles (Xia et al., 2019). No study has
systematically analyzed multiple datasets and brain regions to
identify DNAm patterns resulting from the interaction of sex and
age during lifespan, and most importantly no study has evaluated
whether sex- and age-dependent DNAm can contribute to
epigenetic deregulation in AD, despite the pivotal role of these
two factors in AD etiology and pathogenesis.
To fill this gap, in the present paper we performed a meta-
analysis of DNAm across sex, age, and AD considering publicly
available datasets from different brain regions.
MATERIALS AND METHODS
Datasets
To select DNAm datasets based on Infinium BeadChip
technology, the Gene Expression Omnibus (GEO) repository
(Clough and Barrett, 2016) was interrogated by the GEOmetadb
Bioconductor package using the following search terms:
“GPL13534,” “GPL21145,” to include only datasets based on the
Illumina InfiniumHumanMethylation450 andMethylationEPIC
BeadChips; “sex,” “gender,” “female,” to include only datasets in
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which the information on the sex of the subjects was available;
“age,” to include only datasets in which the information on the
age of the subjects was available; “brain,” “cortex,” “gyrus,” “lobe,”
“gray,” to select datasets in which brain samples were analyzed;
“control,” “normal,” “non-tumor,” “health,” or “Alzheimer,” “AD,”
“Braak,” to select datasets including healthy and AD subjects,
respectively. We considered only datasets including more than
10 healthy subjects. As to June 30th 2020, only Illumina Infinium
HumanMethylation450 datasets were retrieved.
For the meta-analysis of sex- and age-dependent DNAm in
healthy subjects, we selected only datasets including at least 10
males and 10 females, having more than 19 years and spanning
an age range of at least 30 years. We further considered only
brain regions for which at least two datasets were available.
This resulted in eight datasets covering four regions: Frontal
cortex (FC), Temporal cortex (TC), Entorhinal cortex (ERC),
Cerebellum (CRB) (Table 1).
For the meta-analysis of AD-associated methylation patterns,
we selected only the datasets including subjects over 65 years of
age with at least 3 males and 3 females in the control and AD
groups. This resulted in eight datasets covering the same brain
regions indicated above (Table 2).
Pre-processing
As raw intensities files were not available for some datasets,
all the analyses were performed on pre-processed methylation
data downloaded from GEO. Potentially ambiguous probes
(cross-reactive probes and probes including SNPs; Zhou et al.,
2017) were excluded from the analyses. Probes mapping on
sex chromosomes were removed, except when the comparison
between AD and healthy controls was performed in males
and females separately. GSE134379, GSE125895, GSE66351, and
GSE76105 did not include probes mapping on sex chromosomes
in the pre-processed data downloaded from GEO.
TABLE 1 | Characteristics of the Infinium450k datasets including healthy subjects












GSE105109 Entorhinal cortex 27 13/14 58–99
Cerebellum 28 14/14 58–99
GSE125895 Frontal cortex 47 19/28 51.83–83.64
Entorhinal cortex 49 20/29 51.83–83.64
GSE134379 Temporal cortex 179 76/103 63–103
Cerebellum 179 76/103 63–103
GSE59685 Frontal cortex 24 12/12 55–95
Temporal cortex 26 13/13 40–95
Cerebellum 23 10/13 40–95
GSE74193 Frontal cortex 216 68/148 19.26–85.2
GSE64509 Frontal cortex 40 22/18 32–114
Cerebellum 31 21/10 38–114
GSE66351 Frontal cortex 25 10/15 46–88
Temporal cortex 25 10/15 46–88
In each dataset, neuron/glia proportions were estimated using
Horvath’s calculator (Horvath, 2013) which implements the
algorithm developed by Guintivano et al. (2013).
For the analysis of 5-methylcytosine (5mC), 5-
hydroxymethylcytosine (5hmC), and unmethylated cytosine
(5uC) in the GSE105109 dataset, we considered only the samples
for which both bisulfite (BS) and oxidative bisulfite (oxBS) were
available. ERC included 25 healthy subjects (12 females and
13 males) and 57 AD (25 females and 32 males), while CRB
included 28 healthy subjects (14 females and 14 males) and 63
AD (26 females and 37 males). OxBS beta values correspond to
5mC levels; 5hmC levels were calculated by subtracting oxBS
TABLE 2 | Characteristics of the Infinium450k datasets investigated in the present











GSE105109 Entorhinal cortex Ctrl 24 13/11 66–99
Entorhinal cortex AD 61 27/34 67–97
Cerebellum Ctrl 25 13/12 66–99
Cerebellum AD 64 27/37 67–97
GSE125895 Frontal cortex Ctrl 11 5/6 65.04–83.64
Frontal cortex AD 18 9/9 71.47–92.29
Entorhinal cortex Ctrl 12 5/7 65.04–83.64
Entorhinal cortex AD 17 10/7 71.47–92.29
Cerebellum Ctrl 8 4/4 65.04–83.64
Cerebellum AD 20 11/8 71.47–92.29
GSE134379 Temporal cortex Ctrl 175 76/99 68–103
Temporal cortex AD 217 117/100 66–102
Cerebellum Ctrl 175 74/95 68–103
Cerebellum AD 217 117/100 66–102
GSE59685 Frontal cortex Ctrl 21 10/11 66–95
Frontal cortex AD 60 39/21 66–103
Temporal cortex Ctrl 22 11/11 66–95
Temporal cortex AD 61 40/21 66–103
Entorhinal cortex Ctrl 19 8/11 66–95
Entorhinal cortex AD 58 19/13 66–95
Cerebellum Ctrl 19 8/11 66–95
Cerebellum AD 60 39/21 66–103
GSE66351 Frontal cortex Ctrl 12 8/4 71–88
Frontal cortex AD 35 22/13 67–97
Temporal cortex Ctrl 12 8/4 71–88
Temporal cortex AD 37 23/14 67–97
GSE76105 Temporal cortex Ctrl 34 18/16 66–94
Temporal cortex AD 34 17/17 66–92
GSE80970 Frontal cortex Ctrl 68 34/34 70–108
Frontal cortex AD 74 54/30 72–103
Temporal cortex Ctrl 70 36/34 70–108
Temporal cortex AD 74 54/30 72–103
GSE109627 Temporal cortex Ctrl 36 19/17 73–94
Temporal cortex AD 46 24/22 70–95
Ctrl, healthy subjects; AD, Alzheimer’s disease patients.
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beta values from BS beta values (BS-oxBS), while 5uC levels were
calculated by subtracting BS beta values from 1 (1-BS; Lardenoije
et al., 2019). Negative values returning from the difference
BS-oxBS were set to a value close to zero (1 × 10−7; Ringh et al.,
2019).
Differential Analysis and Meta-Analysis
To identify differentially methylated positions (DMPs), the lmFit
function implemented in limma R package (Ritchie et al.,
2015) was used to fit a linear model to each microarray
probe, expressing DNAm as M-values. Association with age
was calculated using age as a continuous value and correcting
for sex and neuron/glia proportion. Association with sex was
calculated using sex as a categorical value and correcting for age
and neuron/glia proportion. Association with AD was calculated
using AD as a categorical value and correcting for age, sex and
neuron/glia proportion. The lmFit function was used also to
calculate the interaction between sex and age, correcting for
neuron/glia proportion, and between AD and sex, correcting
for age and neuron/glia proportion. Effect sizes and standard
errors were extracted from limma output. For each brain region,
the results obtained in the different datasets were combined
by inverse variance-weighted fixed-effects meta-analysis using
METAL software (Willer et al., 2010). Finally, the p-values
resulting from each meta-analysis were adjusted for multiple
comparisons using the Benjamini-Hochberg (BH) procedure.
Only probes with a BH-corrected p-value <0.01 and with
concordant effect sizes between all the datasets included in each
meta-analysis were retained as significant.
To identify DMPs specific for a certain brain region, we first
selected the probes having a BH-corrected p-value <0.01 in one
region and a BH-corrected p-value >0.01 in all the other regions;
we further refined these lists by selecting the probes having large
effect sizes (<5th percentile or >95th percentile) in the brain
region under investigation and small absolute effect sizes (<0.1
for sex analysis; <0.001 for age analysis; <0.1 for AD analysis) in
all the other regions.
Enrichment and Gene Ontology Analysis
Enrichment of genomic regions (islands, N- and S-shores and
shelves, open sea regions) was calculated using Fisher exact
test, as implemented in the fisher.test function from the stats
R package (p-value <0.05). Enrichment of Gene Ontology
(GO) terms was calculated using the methylgometh function
implemented in the methylGSA R package (Ren and Kuan,
2019), and redundant significant GO terms (BH-corrected p-
value <0.01) were removed by REViGO software (Supek et al.,
2011).
RESULTS
The selection criteria of publicly available DNAm datasets of
healthy and AD human brains are described in Materials and
Methods section, and the datasets included in the meta-analysis
are reported in Tables 1, 2. An overview of the study design is
reported in Supplementary Figure 1.
DNA Methylation Differences Across Sex
To identify sex-dependent differentially methylated positions
(sDMPs) we performed an epigenome wide association study
(EWAS) in each dataset and brain region separately, considering
healthy subjects and correcting for age and estimated neuron/glia
proportion (SectionMaterials andMethods). We then conducted
a meta-analysis within each brain region.
We identified 4,860 sDMPs in FC, 1,985 sDMPs in TC,
159 sDMPs in ERC, and 2,322 sDMPs in CRB (Figures 1A–D,
Supplementary Figure 2, and Supplementary File 1).
In FC, sDMPs were mainly hypermethylated in males
compared to females (73% of hypermethylated probes) while
the opposite was true for TC, ERC, and CRB (38, 33, and 36%
of hypermethylated probes in TC, ERC, and CRB, respectively).
When analyzing the genomic context of the sDMPs, we found
that CpG islands were enriched in sDMPs in all the four
brain regions, and that CpG island shores showed a similar
trend (Supplementary File 2). Also the distribution of sDMPs
across chromosomes was not random, with a trend toward
enrichment in chromosome 19 in all the four brain regions.
The enrichment analysis of GO terms did not reveal significant
results except for FC, where the “homophilic cell adhesion via
plasma membrane adhesion molecules” ontology was found
(Supplementary File 2).
To investigate whether sex-dependent DNAm changes were
consistent across brain regions, we evaluated the correlation
of effect size values between FC, TC, ERC, and CRB
(Figure 2A). The four brain regions were positively correlated
each other. We next intersected the 4 sDMPs lists, identifying 77
common probes mapping in 57 genes (Figure 2D, Table 3, and
Supplementary File 1).
All these probes showed concordant sex-dependent DNAm
profiles in the four brain regions and most of them (73%)
were hypomethylated in males. Furthermore, 93% of them were
previously described to have sex-dependent DNAm also in whole
blood (Yusipov et al., 2020).
On the other hand, we searched for probes having sex-related
DNAm differences only in one brain region (region-specific
sDMPs; Section Materials and Methods). We found 2, 4, 0, and
37 region-specific sDMPs in FC, TC, ERC, and CRB, respectively
(Supplementary File 1). Interestingly five sDMPs specific for
CRB mapped in Nuclear Enriched Abundant Transcript 1
(NEAT1) gene (Figure 3).
DNA Methylation Changes Across Age
To identify age-dependent differentially methylated
positions (aDMPs) we performed an EWAS in each
dataset and brain region separately, considering
healthy subjects and correcting for sex and estimated
neuron/glia proportion (Section Materials and Methods).
We then conducted a meta-analysis within each
brain region.
We identified 24,581, 10,077, 404, and 1,140 aDMPs
in FC, TC, ERC, and CRB, respectively (Figures 1E–H,
Supplementary Figure 3E, and Supplementary File 3). In all
brain regions, most of the aDMPs underwent hypermethylation
with age (76, 88, 58, and 62% of hypermethylated aDMPs
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FIGURE 1 | Sex-, age-, and AD-associated epigenetic changes in the four brain regions. Volcano plots of -log10(P-value) against effect sizes, resulting from the
meta-analysis of: (i) sex-associated DMPs in FC (A), TC (B), ERC (C), and CRB (D); (ii) age-associated DMPs in FC (E), TC (F), ERC (G), and CRB (H); (iii)
AD-associated DMPs in FC (I), TC (J), ERC (K), and CRB (L). Significant probes (BH-corrected p-value <0.01) are colored in black.
in FC, TC, ERC, and CRB, respectively). The genomic
context of aDMPs was not consistent across the four brain
regions, except for a significant under-representation in “open
sea” regions (Supplementary File 4). Similarly, aDMPs were
differently scattered across chromosomes in FC, TC, ERC, and
CRB. GO enrichment analysis revealed several pathways involved
in morphogenesis and developmental processes, with “pattern
specification process” and “regionalization” common to FC, TC,
and ERC (Supplementary File 4).
The analysis of correlation between the effect sizes revealed
that age-associated changes were more similar between FC and
TC compared to the other regions (Figure 2B). The intersection
of the aDMPs from the 4 brain regions highlighted 28 common
probes, all concordantly undergoing hypermethylation with age
and mapping in 25 genes (Figure 2E and Table 4). Again, 93% of
these probes were reported as age-associated also in while blood
(Yusipov et al., 2020).
The opposite analysis, i.e., the identification of region-
specific aDMPs (section Materials and Methods), identified
only one probe specific for FC (cg01725130), that maps
in the body of Ras And Rab Interactor 3 (RIN3) gene
(Supplementary File 2).
The Relation Between Age and Sex in Brain
DNA Methylation
We then aimed at studying how sex-specific brain DNAm is
modulated during aging.
First of all, we intersected sDMPs and aDMPs lists. In
FC, we found 675 probes that change with sex and with
age (s&aDMPs), corresponding to about 13% of all sDMPs
identified. In TC s&aDMPs were 171, corresponding to 8.5%
of sDMPs. In ERC we found only 2 s&aDMPs, while in CRB
s&aDMPs were 19, corresponding to 4% of sDMPs (Figure 4
and Supplementary Files 1, 3). In all the four regions, the
proportion of sDMPs changing with age (i.e., the proportion
of s&aDMPs) was higher than expected (Fisher’s Exact Test
p-value <0.05; odds ratio of 2.6, 3.8, 13.0, and 3.0 in FC,
TC, ERC, and CRB, respectively). In FC, TC, and CRB, most
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FIGURE 2 | Cross-region analysis of sex-, age-, and AD-associated probes. (A–C) The correlation matrix plots show the magnitude of correlation among probes’
effect sizes in the four brain regions, considering the results of the meta-analysis on sex- (A), age- (B), and AD- (C) associated probes. Positive and negative
correlation values are indicated in blue and red, respectively. (D–F) The Venn diagrams display the number of significant DMPs shared between the four brain regions,
considering sDMPs (D), aDMPs (E), and AD-DMPs (F). The genes in which the most shared probes map are reported below each diagram.
of the s&aDMPs were probes having higher DNAm levels
in males respect to females and undergoing hypermethylation
during aging. GO analysis revealed only one ontology enriched
in FC (“homophilic cell adhesion via plasma membrane
adhesion molecules”).
The previous analysis identifies CpG probes whose DNAm
varies according to both sex and age, but is not informative
about possible differences in aging trajectories between males
and females. To fulfill this point, we performed an age-by-
sex interaction analysis in each dataset (Section Materials and
Methods) and meta-analyzed the results for the four brain
regions. Only 4, 4, 2, and 2 probes showed a significant age-
by-sex interaction in FC, TC, ERC, and CRB, respectively
(Supplementary File 5).
Brain DNA Methylation Changes Across AD
Then, we focused on brain DNAm datasets including late-onset
AD patients and age-matched non-demented controls.
To identify differentially methylated positions associated with
AD (AD-DMPs) we performed an EWAS in each dataset and
brain region separately, correcting for age, sex, and estimated
neuron/glia proportion (section Materials and Methods). We
then conducted a meta-analysis within each brain region.
We identified 14 AD-DMPs in FC, 5405 in TC, 47 in ERC,
and only 1 in CRB (Figures 1I–L, Supplementary Figure 4,
and Supplementary File 6). In all brain regions most of AD-
DMPs were hypermethylated in AD compared to controls (93,
80, 76, and 100% in FC, TC, ERC, and CRB, respectively).
While in TC AD-DMPs were significantly under-represented
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TABLE 3 | sDMPs resulting from cross-region analysis.
Probe Chr MAPINFO Relation Gene Effect size
direction
Yusipov et al. Cited in previous studies in
relation to sex
cg00097357 12 33591336 N_Shore SYT10 - X
cg00655923 7 64895418 + X
cg00760935 4 15541 Island DCHS2 - X
cg01063965 11 695461 Island TMEM80, DEAF1 - Involved in sex-dependent anxiety
and depression (Luckhart et al., 2016;
Philippe et al., 2018)
cg01181499 2 74739419 N_Shore - X
cg01906879 3 81811016 S_Shore GBE1 - X
cg02093808 4 77342011 Island - X
cg02297043 1 75590912 Island - X
cg02530860 8 14436 Island + X
cg03168896 3 44036098 N_Shore - X
cg03405128 4 77341841 N_Shore - X
cg03687700 2 24271844 N_Shore FKBP1B - X
cg03894796 8 13783 Island + X
cg04946709 16 59789030 Island LOC644649 + X
cg05020125 8 37605552 LOC728024, ERLIN2 - X
cg05056638 8 24800824 S_Shore - X
cg05100634 18 45457604 Island SMAD2 - Sex-differences in extracellular matrix
production (Wu et al., 2015;
Dworatzek et al., 2016; Altinbas et al.,
2019; Avouac et al., 2020)
cg05468028 21 30391383 Island RWDD2B - X
cg05849319 11 65172370 Island FRMD8 + X
cg06666376 19 3480596 N_Shore C19orf77 + X
cg06710937 13 23489940 Island - X
cg07462804 4 81105375 Island PRDM8 - X
cg07645761 16 2892518 N_Shore TMPRSS8 + X
cg07953307 16 29000920 LAT + X
cg08541880 3 13783 Island DZIP1L - X
cg09045105 1 149871 Island BOLA1 - X
cg09725915 2 70369583 Island - X
cg09971754 16 89557657 Island ANKRD11 + X
cg10546176 5 34929404 Island DNAJC21 - X
cg10749792 7 56119218 Island PSPH, CCT6A - X
cg10776186 13 25875020 Island NUPL1 - X Sex-dependent differentially
methylated gene (McCarthy et al.,
2014)
cg11065518 2 20763 S_Shore MDH1B, FASTKD2 - X
cg11174255 4 1513259 N_Shore + X
cg11240062 8 14436 Island + X
cg11565911 12 72233249 N_Shore TBC1D15 - X
cg11841231 2 20554 PARD3B + X
cg12356266 8 99984350 N_Shore - X
cg12611527 2 15725 Island - X
cg12611723 9 139940 Island NPDC1 - X
cg13230424 17 45930033 S_Shore SP6 - X
cg13346869 8 37605517 LOC728024, ERLIN2 - X
cg14030268 10 11913 Island PDZD8 - X
cg14373579 9 13345 Island LOC100272217, FUBP3 - X
cg15148078 19 3480561 N_Shore C19orf77 + X
(Continued)
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TABLE 3 | Continued
Probe Chr MAPINFO Relation Gene Effect size
direction
Yusipov et al. Cited in previous studies in
relation to sex
cg15817705 1 20940 S_Shore + X
cg16021159 1 57142074 PRKAA2 + X
cg16374663 15 41805031 Island LTK - X
cg17561891 7 86849173 Island C7orf23 - X
cg17743279 7 92463268 Island CDK6 - X
cg17887478 17 7486551 Island MPDU1 - X
cg18001427 21 30391784 S_Shore RWDD2B - X
cg18721420 19 15121913 Island CCDC105 - X
cg19292062 20 524344 Island CSNK2A1 - X
cg19311244 4 77341912 N_Shore - X
cg19864758 20 17206720 Island PCSK2 - X
cg20050113 2 103236861 S_Shore SLC9A2 - X Sex-dependent differentially
methylated gene (McCarthy et al.,
2014)
cg20432211 4 77342104 Island - X
cg22105158 19 3480672 N_Shore C19orf77 + X
cg22266749 4 110223 Island COL25A1 + X
cg22345911 17 80231263 Island CSNK1D - X
cg22794378 14 89029563 Island ZC3H14 -
cg22799420 14 102028994 Island DIO3 - X Sex-dependent regulation and
functions (Sittig et al., 2011; Kim
et al., 2019; Stohn et al., 2019; Stone
et al., 2019)
cg22889142 19 58862398 Island NCRNA00181, A1BG - X Female-specific gene expression in
liver (Gardmo and Mode, 2006;
Conforto et al., 2012)
cg23001456 17 2615074 Island KIAA0664 - X
cg23719534 15 10109 Island -
cg23880736 4 582172 Island + X
cg24016844 1 11150 Island C1orf103 + X
cg24126849 4 581937 N_Shore + X
cg24158363 17 73401717 Island GRB2 - X
cg24717799 15 83680832 S_Shore C15orf40 - X
cg24990494 13 32520050 EEF1DP3 +
cg25584814 19 345306 Island MIER2 - X
cg25726513 4 1340596 Island KIAA1530 - X
cg26172013 20 32031452 Island SNTA1 - X
cg26516287 7 12629275 SCIN - X
cg26612727 17 38024636 Island ZPBP2 - X Sex-dependent DNA methylation (Ho
et al., 2018)
cg27645294 17 21795257 - X
in CpG islands and enriched in the other genomic contexts, a
significant enrichment in CpG islands was found for AD-DMPs
identified in FC (Supplementary File 7). GO analysis returned
significant results only in TC, where pathways related to synapse
organization and function were found (Supplementary File 7).
Correlation analysis of effect sizes between the four brain
regions highlighted a distinctive pattern in CRB respect to FC,
TC, and ERC, while the correlation was higher between TC
and ERC (Figure 2C). Accordingly the intersection between AD-
DMPs in the 4 brain regions did not return common probes,
while 29 probes (mapping in 23 genes) and 8 probes (mapping
in 6 genes) were identified by intersecting TC and ERC or
FC and TC, respectively (Figure 2F and Table 5). The probe
cg12163800, mapping in Rhomboid 5 Homolog 2 (RHBDF2)
gene, was significantly hypermethylated in FC, TC, and ERC from
AD patients. A comparison with AD-associated probes retrieved
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FIGURE 3 | CRB-specific sex-associated DNAm of NEAT1 gene. Forest plots of three CRB-specific sDMPs mapping in NEAT1gene: (A) cg16884222, (B)
cg09411730, (C) cg07985890. For each probe, effect sizes from the datasets used for our meta-analysis are reported, dividing them according to the four brain
regions (CRB, yellow; FC, magenta; TC, cyan; ERC, gray).
in a recent meta-analysis (Smith R. G. et al., 2020) is also reported
in Table 5.
Confirmation of Sex- and Age-Associated
DNAm Changes in AD Subjects
We investigated whether the sDMPs and aDMPs identified
above in the different brain regions from healthy controls were
confirmed also in AD patients. To this aim, we evaluated
their association with sex (correcting for age and estimated
neuron/glia proportion) or with age (correcting for sex and
estimated neuron/glia proportion) considering DNAm data
from AD samples, and performed a meta-analysis in each
brain region. The effect sizes obtained in AD were highly
correlated with those previously obtained in healthy controls
(Supplementary Figure 5). This correlation was slightly lower
for aDMPs, which is expected considering that in most datasets
the age range tends to be narrower for AD samples compared
to healthy controls. Interestingly, also in AD samples we found
an enrichment of sDMPs on chromosome 19 (data not shown).
Collectively, these results indicate that sex- and age-dependent
DNAm patterns are largely reproduced in AD samples.
The Relationship Between Sex- and
Age-Associated DNAm Changes and AD
Epigenetic Remodeling
We explored whether AD-associated DNAm changes were
related to sex- and age-specific brain DNAm patterns
occurring in physiological conditions, identified in the analyses
described above.
In each brain region, we intersected the AD-DMPs and
sDMPs in order to identify AD&sDMPs, i.e., probes that have
basal differential DNAm between the two sexes and are also
affected by AD. The intersection did not result in any probe
for all the regions except that for TC, where we found 23
AD&sDMPs, mapping in 16 genes and corresponding to only
0.4% of AD-DMPs in TC (Fisher’s Exact Test p-value >0.05;
Figure 4 and Supplementary Files 1, 6). Moreover, AD-by-sex
interaction analysis yielded no significant probes in any region.
To further explore the epigenetic relationship between sex
and AD, we extended our analysis to probes located on sex
chromosomes and focused on AD datasets in which their DNAm
values were available (Section Materials and Methods). For each
dataset, we considered males and females separately, we repeated
the EWAS for AD-associated DNAm and we performed the
meta-analysis within each brain region. We then searched for
significant AD-DMPs located on the X or Y chromosomes.
This analysis returned only few probes: four X-linked DMPs
were found in TC when males with and without AD were
compared, while one X-linked probe was found in male ERC
(Supplementary File 6).
Similarly, we explored whether AD-DMPs occur in probes
whose DNAm varies during physiological aging (AD&aDMPs).
The intersection between AD-DMPs and aDMPs highlighted 7,
456, 4, and 0 probes in FC, TC, ERC, and CRB, respectively
(Figure 4). The proportion of AD&aDMPs was higher than
expected by chance in FC, TC, and ERC (Fisher’s Exact Test
p-value <0.05; odds ratio of 15.9, 3.8, and 95 in FC, TC,
and ERC, respectively). We found that 87% of AD&aDMPs
in TC are concordant for the effect size sign between aDMPs
and AD-DMPs, while this percentage reached 100% in FC and
ERC. Notably, the four AD&aDMPs found in ERC (cg11823178,
cg03169557, cg25018458, and cg22090150) were also found in
TC (Table 6). Also the intersection between AD&aDMPs in TC
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TABLE 4 | aDMPs resulting from cross-region analysis.
Probe Chr MAPINFO Relation Gene Effect size
direction
Yusipov et al. Cited in previous studies in
relation to age
cg00292135 7 156433068 Island C7orf13, RNF32 + X
cg04090392 15 83952774 Island BNC1 + X Testicular premature aging (Li J. Y.
et al., 2020)
cg06639320 2 106015739 Island FHL2 + X Epigenetic changes in aging
(Garagnani et al., 2012; Steegenga
et al., 2014; Bacos et al., 2016;
Kananen et al., 2016; Bacalini et al.,
2017; Spólnicka et al., 2018b)
cg06942814 7 27170819 S_Shore HOXA4 + X Epigenetic dysregulation in progeroid
syndrome (Maierhofer et al., 2019)
cg07303143 3 44803452 Island KIAA1143, KIF15 + X
cg07525420 10 131761181 Island EBF3 + X
cg07922606 6 26225389 Island HIST1H3E + Regulation of age-dependent gene
expression (Crossland et al., 2017)
cg11614451 3 160167729 Island TRIM59 + Epigenetic changes in aging
(Spólnicka et al., 2018a,b; Wezyk
et al., 2018)
cg12373771 22 17601381 Island CECR6 + X
cg13327545 10 22623548 Island + X
cg14020846 14 103674272 Island + X
cg14556683 19 15342982 Island EPHX3 + X
cg15243034 11 77907656 Island USP35 + X
cg15341124 14 102027734 Island DIO3, MIR1247 + X Age-dependent expression (McCann
and Ames, 2011; Kim et al., 2014;
White et al., 2015; Mikovic et al.,
2018; Wang et al., 2020)
cg15611336 15 75248496 Island RPP25 + X
cg16295725, 4 10459219 Island ZNF518B + X Pancreatic aging (Bacos et al., 2016;
Bou Sleiman et al., 2020)
cg23995914 10459228
cg16867657 6 11044877 Island ELOVL2 + X Epigenetic changes in aging
(Garagnani et al., 2012; Steegenga
et al., 2014; Rönn et al., 2015;
Bacalini et al., 2017; Slieker et al.,
2018; Spólnicka et al., 2018b; Sturm
et al., 2019; Chao and
Skowronska-Krawczyk, 2020; Chen
et al., 2020; Li X. et al., 2020)
cg16969368 17 57642752 Island DHX40 + X
cg18008766 2 38978896 S_Shore SFRS7 + X
cg18240400 10 46168597 Island ANUBL1 + X
cg18473521 12 54448265 S_Shore HOXC4 + X
cg19399220 19 10527588 Island + X
cg20591472 1 110008990 Island SYPL2 + X
cg24079702 2 106015771 Island FHL2 + X Epigenetic changes in aging
(Garagnani et al., 2012; Steegenga
et al., 2014; Bacos et al., 2016;
Kananen et al., 2016; Bacalini et al.,
2017; Spólnicka et al., 2018b)
cg24567591 16 3931229 Island CREBBP + X Memory performance in elderly
(Barral et al., 2014)
cg24903144 10 102509268 Island PAX2 + X Retina aging (Mansour et al., 2008)
cg26092675 6 26225258 N_Shore HIST1H3E + X Regulation of age-dependent gene
expression (Crossland et al., 2017)
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FIGURE 4 | Intersections of sex-, age-, and AD-associated probes in each of the four brain regions. Venn diagrams depict the intersection between sDMPs, aDMPs,
and AD-DMPs in FC (A), TC (B), ERC (C), and CRB (D).
and FC returned four common probes (cg01463828, cg04874795,
cg22962123, and cg07061298; Table 6). Figure 5 reports DNAm
values of cg11823178 (ANK1) and cg22962123 (PDLIM2) in TC
from GSE134379 dataset as an example of CpG sites displaying
a positive association of DNAm with age and hypermethylated
in AD.
Finally, it is worth to note that TC is the only brain region
in which we found probes at the intersection between aDMPs,
sDMPs, and AD-DMPs (AD&a&sDMPs; Figure 4B). The five
probes (cg20225999, cg03951603, cg08820801, cg22263793,
cg10828284; Table 7) were all hypermethylated in males and with
aging; three of them (cg20225999, cg08820801, cg10828284) were
further hypermethylated in AD.
Contribution of 5-hydroxymethylcytosine
to the Epigenetic Changes Across Sex,
Age, and AD
All the analyses reported above are based on microarray data
from BS converted DNA. BS treatment does not allow to
distinguish between 5mC and 5hmC, another epigenetic mark
which plays an important role especially in the brain (Kriaucionis
and Heintz, 2009; Lunnon et al., 2016). On the contrary, the
combination of BS with oxBS treatment allows discriminating the
levels of 5mC, 5hmC, and 5uC in DNA (Booth et al., 2012). One
of the datasets that we used in our meta-analysis for sex-, age-
, and AD-associated epigenetic changes (GSE105109) includes
microarray results from matched BS- and OxBS-treated ERC
and CRB samples. We calculated the levels of 5mC, 5hmC, and
5uC (Section Materials and Methods) in this dataset and we
analyzed them for the association with sex (in healthy subjects),
with age (in healthy subjects), and with AD (comparing AD and
healthy subjects). This analysis did not return any significant
probe, neither in ERC nor in CRB. We then considered the
lists of sDMPs, aDMPs, and AD-DMPs identified in the meta-
analysis of ERC and CRB datasets, and used GSE105109 data
to investigate the contribution of 5mC, 5hmC, and 5uC to the
observed epigenetic changes. Supplementary Figure 6 reports
the correlation between the effect size values resulting from the
meta-analysis of sex, age, and AD, and the effect size values
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TABLE 5 | AD-DMPs resulting from cross-region analysis.
Intersection Probe Chr MAPINFO Relation Gene Effect size
direction
Smith et al. Cited in previous studies in
relation to AD
TC ∩ ERC cg00851830 14 100201016 N_Shelf +
cg03169557 16 89598950 SPG7 + X Retinal nerve fiber layer loss; AD DMP
(Wiethoff et al., 2012; Li Q. S. et al.,
2020)
cg03183618 2 134964228 +
cg04658038 17 64800166 PRKCA + Synaptic degeneration (Wang et al.,






ANK1, MIR486 + X Epigenetic changes in AD; involved in
memory loss (De Jager et al., 2014;
Lord and Cruchaga, 2014; Lunnon
et al., 2014; Chi et al., 2016;
Mastroeni et al., 2017; Gasparoni
et al., 2018; Higham et al., 2019;
Blanco-Luquin et al., 2020; Li Q. S.
et al., 2020)
cg05397697 14 90042217 PRO1768, FOXN3 +
cg05417607 17 1373605 N_Shore MYO1C + X
cg05810363, 17 74475270 Island RHBDF2 + X Epigenetic changes in AD (De Jager
et al., 2014; Lord and Cruchaga,




cg06653632 12 129281444 S_Shore SLC15A4 +
cg06753513 17 3977385 ZZEF1 +
cg07012687 17 80195180 Island SLC16A3 +
cg07571519 10 73472315 C10orf105, CDH23 + Expression and epigenetic changes in
AD (De Jager et al., 2014; Lord and
Cruchaga, 2014; Humphries et al.,
2015; Hu et al., 2018)
cg09123026 17 74480528 RHBDF2 + Epigenetic changes in AD (De Jager
et al., 2014; Lord and Cruchaga,
2014; Zou et al., 2019; Li Q. S. et al.,
2020)
cg13851211 16 50321678 ADCY7 +
cg14025831 20 3873404 S_Shelf PANK2 +
cg14761246 3 182968758 N_Shelf MCF2L2 +
cg14798745 4 184315677 N_Shelf +
cg18102633 19 17487776 N_Shore PLVAP +
cg18456331 10 77188318 N_Shelf +
cg18923906 10 82225771 TSPAN14 +
cg20148994 7 130125585 N_Shore MEST +
cg21221455 15 63342288 S_Shore TPM1 +
cg22090150 17 4098227 ANKFY1 + X
cg22656126 17 1637206 Island WDR81 +
cg25018458 17 980014 N_Shore ABR + X Hearing loss (Irimajiri et al., 2005; Oh
et al., 2010; O’Leary et al., 2017;
Hacohen-Kleiman et al., 2019; Liu
et al., 2020)
cg27630153 16 88845038 Island FAM38A +
FC ∩ TC ∩ ERC cg12163800 17 74475355 Island RHBDF2 + X Epigenetic changes in AD (De Jager
et al., 2014; Lord and Cruchaga,
2014; Zou et al., 2019; Li Q. S. et al.,
2020)
(Continued)
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TABLE 5 | Continued
Intersection Probe Chr MAPINFO Relation Gene Effect size
direction
Smith et al. Cited in previous studies in
relation to AD
FC ∩ TC cg01463828 8 22446721 PDLIM2 + X
cg02317313 12 122 Island LOC338799 + X
cg04874795 16 86477638 - X
cg07061298 7 27153847 N_Shore HOXA3 + X Epigenetic changes in AD (Gasparoni
et al., 2018; Hernández et al., 2018;
Smith et al., 2018; Li Q. S. et al.,
2020)
cg12163800 17 74475355 Island RHBDF2 + X Epigenetic changes in AD (De Jager
et al., 2014; Lord and Cruchaga,
2014; Zou et al., 2019; Li Q. S. et al.,
2020)
cg22962123 7 27153605 Island HOXA3 + X
cg26022064 7 98739782 N_Shore SMURF1 + X Neural necroptosis and Hirano bodies
(Makioka et al., 2014; Shao et al.,
2018)
cg26199857 12 54764265 Island ZNF385A +
FC ∩ ERC cg12163800 17 74475355 Island RHBDF2 + X
cg13076843 74475294
TABLE 6 | AD&aDMPs resulting from cross-region intersections.
Intersection Probe Chr MAPINFO Relation Gene Effect size direction Smith et al. Yusipov et al.
(Bonf. Corrected aDMPs)
ERC ∩ TC cg11823178 8 41519399 ANK1 + X X
cg03169557 16 89598950 SPG7 + X
cg25018458 17 980014 N_Shore ABR + X
cg22090150 17 4098227 ANKFY1 + X
FC ∩ TC cg22962123 7 27153605 Island HOXA3 + X X
cg07061298 7 27153847 N_Shore HOXA3 + X
cg04874795 16 86477638 - X X
cg01463828 8 22446721 PDLIM2 + X
obtained in GSE105109 dataset using 5mC, 5hmC, and uC values
in the association analysis. In both ERC and CRB, sDMPs and
AD-DMPs showed high correlation between BS (5mC+5hmC)
results and oxBS (5mC) results, while the correlation with 5hmC
results was low. A similar trend was observed for aDMPs in
CRB. This indicates that 5mC is the main contributor to the
epigenetic changes observed for the sDMPs and the AD-DMPs in
ERC and CRB, and for the aDMPs in CRB. On the contrary, for
ERC aDMPs, BS-effect sizes were similarly correlated with 5mC-
and 5hmC-effect sizes, indicating that both the epigenetic marks
are remodeled during aging in this brain region. Furthermore,
age-associated changes in 5mC and 5hmC were likely to involve
different probes, as 5mC and 5hmC effect sizes were not
clearly correlated.
DISCUSSION
Sex and age are among the major risk factors for AD. In this
paper, we performed a meta-analysis of DNAm changes that are
associated to sex and aging in four brain regions (FC, TC, ERC,
CRB) and we evaluated whether they contribute to the epigenetic
alterations that have been widely described in AD. Our main
findings are discussed in the following paragraphs.
Sex-Dependent DNAm Differences Tend to
Be Shared Between Brain Regions, With
Few Exceptions
To date some studies have reported DNAm sex differences in
human brain, mainly focusing on frontal cortex (Xu et al., 2014;
Spiers et al., 2015; Masser et al., 2017; Perzel Mandell et al., 2020)
with few exceptions (Xia et al., 2019). Ourmeta-analysis confirms
the presence of autosomic probes with differential methylation
between males and females in all the brain regions. These probes
preferentially map in CpG islands and shores suggesting their
involvement in the regulation of sex-specific gene expression
in brain (Xu et al., 2014). Surprisingly, in all the brain regions
we found an enrichment of sDMPs in chromosome 19. This
observation is difficult to be explained but a similar result
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FIGURE 5 | Scatter plots of ANK1 and PDLIM2 DNAm according to age and disease. Scatter plots of methylation values of cg11823178 within ANK1 (A) and of
cg22962123 within PDLIM2 (B) in TC from GSE134379 dataset. Healthy subjects are colored in gray while AD patients are in orange. Regression lines and
confidence intervals within each group are reported.
TABLE 7 | Probes resulting from the intersection between aDMPs, sDMPs, and AD-DMPs in TC.
Probe Chr MAPINFO Relation Gene Effect size direction Smith et al. Yusipov et al. Yusipov et al.
cg20225999 2 218843435 N_Shore + X X
cg03951603 15 89903565 Island - X
cg08820801 19 39465821 N_Shore FBXO17 + X
cg22263793 19 42501398 Island - X
cg10828284 22 50528333 Island MOV10L1 + X
was observed in a precedent study on sex-associated DNAm
differences across childhood in whole blood (Suderman et al.,
2017). Chromosome 19 has the highest content of CpG sites and
genes in the genome (Grimwood et al., 2004), and seems to be
involved in the process of X chromosome inactivation (Migeon
et al., 2017).
Sex specific DNAm tended to be reproducible across the brain
regions and 77 CpGs resulted from the cross-region intersection.
Among them there are sDMPs mapping in genes that have
been already associated to sex differences in brain physiology
and pathology, like Par-3 Family Cell Polarity Regulator Beta
(PARD3B) (Phillips et al., 2019), DEAF1 Transcription Factor
(DEAF1) (Luckhart et al., 2016), and Iodothyronine Deiodinase
3 (DIO3) (Stohn et al., 2019) genes. Most of these 77 probes were
previously reported as differentially methylated between males
and females also in previous meta-analysis on blood (McCarthy
et al., 2014; Yusipov et al., 2020).
In addition, we found few examples of sDMPs specific for a
brain region. The most notable example is in cerebellum and
maps in NEAT1. NEAT1 is a ubiquitously expressed long non-
coding RNA (lncRNA) involved in a plethora of neurospecific
processes such as brain development and aging (An et al.,
2018; Pereira Fernandes et al., 2018; Salvatori et al., 2020).
Recent transcriptomic studies on human central nervous system
revealed altered NEAT1 levels in AD (Spreafico et al., 2018),
PD (Simchovitz et al., 2019), and in schizophrenia (Katsel et al.,
2019).
DNAm Tends to Be Differently Remodeled
During Aging According to the Brain
Region
Several studies have analyzed age-associated changes in DNAm
in brain, both comparing fetal vs. adult brains and analyzing
methylation profiles across adulthood (Hernandez et al., 2011;
Horvath et al., 2012; Numata et al., 2012; Day et al., 2013;
Jaffe et al., 2016; Gasparoni et al., 2018; Price et al., 2019). Our
meta-analysis shows that during aging there is an increase in
methylation at specific loci, accordingly to previously published
data on blood (Xiao et al., 2016; Yusipov et al., 2020) and
brain (Hernandez et al., 2011). As previously reported by
Hernandez et al. (2011), also our results support the involvement
of brain aDMPs in GO related to developmental processes
and morphogenesis. Furthermore, our meta-analysis confirms
and extends the observation that the epigenome is differently
remodeled during aging across brain regions (Hernandez et al.,
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2011). In particular we observed that age-associated DNAm
patterns are similar in TC and FC, while they are distinct in ERC
and CRB. CRB was previously described to undergo a peculiar
epigenetic aging, which was decelerated according to Horvath’s
epigenetic clock (Horvath et al., 2015).
The large fraction (93%) of the 28 aDMPs emerged from our
cross region analysis was found also in aging studies on blood
(Yusipov et al., 2020). Among them there are probes mapping
in Four And A Half LIM Domains 2 (FHL2) and ELOVL
Fatty Acid Elongase 2 (ELOVL2) genes, previously reported as
age-associated in a large number of studies on several tissues
(Garagnani et al., 2012; Slieker et al., 2018) including sorted
neuron and glia cells (Gasparoni et al., 2018). According to what
discussed above and to previous results (Bacalini et al., 2017;
Slieker et al., 2018) the effect size of ELOVL2 probe cg16867657
was lower in CRB respect the other regions, but still significant in
our meta-analysis. Elovl2 is an enzyme involved in the elongation
of fatty acids and its functional role in aging has been recently
suggested (Chao and Skowronska-Krawczyk, 2020).
Sites With Sex-Dependent DNAm Are
Similarly Modulated During Aging in Males
and Females
Previous studies in mice and humans suggested that, while sex-
differences in DNAm at certain CpG sites are maintained during
life, other CpG sites show sexually divergent aging patterns, i.e.,
they have a different response to aging in males and females
(Masser et al., 2017). Our meta-analysis supports the fact that
sDMPs have a high propensity to be modulated during aging,
as the number of probes resulting from the intersection of
sDMPs and aDMPs is higher than expected in all the four brain
regions. However, we found only few probes with significant
age-by-sex interaction, indicating similar rather than diverging
changes in DNAm in males and females aging. The discrepancy
between our results and previous findings can be due to different
reasons: for example, while Masser et al. considered only one
dataset including frontal cortex data, here we meta-analyzed
several datasets using selective criteria of concordance between
all datasets from the same brain region; furthermore, we applied
a filtering step that removed potentially ambiguous probes, thus
reducing the potential overlap with Masser’s results. Our results
are more similar to what reported by two independent studies in
blood (McCartney et al., 2019; Yusipov et al., 2020) that showed
that only a small fraction of CpGs have significant age-by-sex
interaction. Further studies on larger cohorts are needed to better
describe sex-dependent DNAm patterns during brain aging.
Epigenetic Changes in AD Are Enriched in
Sites That Show Age-Dependent DNAm
A recent meta-analysis on EWAS studies identified 220 CpGs
associated with AD neuropathology, shared by brain cortical
cortex regions but not by CRB (Smith et al., 2019). The paper
by Smith et al. included several datasets that we used also
in our meta-analysis, with the exception of GSE125895 and
GSE109627, while we did not have access to the ROS/MAP and
RBDDNAm data. Furthermore, while Smith et al. considered the
association with Braak stage, here we used the disease as a binary
trait (affected/unaffected). Despite these differences, our results
largely overlap with those previously reported. In particular, we
did not find AD-related probes common to all the four brain
regions that we investigated, with CRBDNAm less affected by the
pathology. On the contrary, a subset of sites was shared between
FC, TC, and ERC, and about 50% of these probes overlap with
published data. These probes map within genes whose epigenetic
deregulation has been largely documented in AD, including
ANK1, RHBDF2, and HOXA3. On the contrary, we did not find
any overlap when comparing our results on AD brain with CpG
sites identified in AD patients’ blood (Roubroeks et al., 2020),
confirming that the pathology differently affects the two tissues
as recently reported (Wei et al., 2020).
We did not find a significant overlap between AD-DMPs and
sDMPs, nor significant interaction effects between sex and AD.
Overall these results suggest that AD does not predominantly
insist on autosomic sites with sex-specific DNAm. Similarly,
when we repeated our analysis including probes on X and
Y chromosomes (analyzing males and females separately) we
found limited evidence of differential DNAm between AD and
controls in sex chromosomes. Collectively these results suggest
that no profound sex-associated DNAm remodeling occurs in
AD. However, we cannot rule out that more subtle epigenetic
differences exist, both on autosomes and sex chromosomes. It is
possible that these differences did not emerge from our meta-
analysis, due to the stringent selection criteria that we applied
or to the small sample sizes when males and females were
considered separately. Further studies should investigate possible
epigenetic contributions to the different AD risk between the
two sexes.
Conversely, our data show that in FC, TC and ERC, AD-
related epigenetic modifications are significantly enriched in
probes whose DNAm varies with age. Strikingly, we found a
high concordance between the direction of DNAm changes
(hyper or hypo-methylation) in AD&aDMPs, indicating that a
subset of age-associated DNAm changes is exaggerated in AD.
In TC, AD&aDMPs included probes mapping in ANK1, and it is
worth to note that the down-regulation of Ank2 (ANK1 human
ortholog gene) inDrosophila has been associated to memory loss,
neuronal dysfunction and shortened lifespan in a recent report
(Higham et al., 2019). Other interesting genes emerged from our
analysis. Paraplegin (SPG7) mutation leads to shortened lifespan,
environmental stress. and muscular and neuronal degeneration
in Drosophila (Pareek et al., 2018). Mov10 Like RISC Complex
RNA Helicase 1 (MOV10L1) is a putative germline-specific
RNA helicase whose expression has been recently reported to
be tightly correlated with brain development, aging and AD
neurodegeneration (Skariah et al., 2017; Srinivasan et al., 2020).
Overall, these results support a geroscience view (Kennedy
et al., 2014; Sierra, 2020) according to which AD can be
considered a deviation of the physiological aging trajectories
toward accelerated aging. Epigenetic age acceleration was
previously reported in AD neurons, where a pronounced loss
of CpH methylation was found at enhancers, similar to what
observed in aging, and in bulk prefrontal cortex, where epigenetic
age calculated by Horvath’s clock was positively associated with
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neuritic plaques and amyloid load (Levine et al., 2015). It will
be interesting to know whether similar results will be obtained
using the recently published epigenetic clock optimized for brain
tissues (Shireby et al., 2020).
Strengths, Limitations, and Conclusions
To the best of our knowledge, this is the first report in which sex-,
age-, and AD-related DNAm changes are systematically assessed
using the same analytical approach. We used stringent selection
criteria that enabled to select only probes with concordant
DNAm changes in the different datasets. Furthermore, we
considered multiple brain regions and reported similarities and
differences in their epigenetic remodeling. Previous studies
showed that DNAm patterns differ between brain regions
and that they may play a role in brain development and
functional specialization (Ladd-Acosta et al., 2007; Rizzardi
et al., 2019). These “baseline” DNAm differences can mediate
disease mechanisms that are specific for certain brain regions
(Rizzardi et al., 2019), and can be further modified across lifespan
and in response to pathological conditions. Accordingly, brain
areas are differently affected during aging and/or in AD onset
and progression (Peters, 2006; Coupé et al., 2019), and also
other molecular layers like transcriptomics and proteomics show
region-specific changes (Patel et al., 2019; Xu et al., 2019).
On the other side, our study has some limitations. The datasets
that we meta-analyzed largely vary in size and age range of
the assessed subjects, an important aspect for the identification
of aDMPs. Moreover, our meta-analysis included data on BS-
treated DNA and it was therefore not possible to distinguish
5mC from 5hmC, an epigenetic modification that contributes to
both brain function and neurodegeneration (Coppieters et al.,
2014; Ellison et al., 2017; Lardenoije et al., 2019; Smith et al.,
2019). The analysis of the dataset in which 5mC and 5hmC
were distinguishable (thanks to the simultaneous analysis of
BS- and oxBS-treated DNA) suggested that the contribution of
5hmC to sDMPs and AD-DMPs tended to be small. A recent
study showed that in fetal brain autosomal 5hmC levels did
not differ between males and females (Spiers et al., 2017), in
accordance to our results. Global changes in 5hmC have been
reported to occur in AD (Chouliaras et al., 2013; Condliffe
et al., 2014; Coppieters et al., 2014), while microarray-based
genome wide studies identified a limited set of CpG sites whose
hmC levels are associated to the disease (Lardenoije et al., 2019;
Smith et al., 2019). For example, Smith et al. reported that AD-
associated hypermethylation of ANK1 detected on BS-treated
DNA is not due to an increase in 5hmC levels, which on the
contrary decreased in the disease (Smith et al., 2019). Similarly,
in our analysis of AD in ERC most of the significant associations
were due to changes in 5mC and we did not observe an
evident co-variation of 5mC and 5hmC. On the contrary, when
considering aDMPs in ERC we found a contribution of both
5mC and 5hmC, and the two epigenetic marks tended to involve
different CpG sites. Age-associated increase in 5hmC levels has
been previously reported (Chouliaras et al., 2012). Although
potentially interesting, these results are based on only one dataset,
and the analysis of the coordinated regulation of brain 5mC
and 5hmC across sex, age, and AD deserves further studies.
Another limitation of our study is that the datasets that we
meta-analyzed were based on bulk brain tissues. Although all the
analyses were corrected for neuron/glia proportions predicted
fromDNAmdata, we cannot exclude that the observed sex-, age-,
and AD-associated DNAm changes are at least in part driven by
changes in brain cells composition that occur in physiological and
pathological conditions. For example, Gasparoni et al. reported
thatANK1 deregulation in AD is specific for glial cells (Gasparoni
et al., 2018), a finding further supported by gene expression
studies (Mastroeni et al., 2017), and that the epigenetic profiles
of neurons and glia are differently modulated during aging.
Notwithstanding, our results suggest that the (cell-specific) age-
associated remodeling of DNAm is not just a confounding factor
for the epigenetic deregulation observed in AD, but on the
contrary, it is the predisposing milieu in which AD pathogenetic
mechanisms are established.
In conclusion, we suggest that age-associated DNAm patterns
concur to the epigenetic deregulation observed in AD, providing
new insights on how advanced age enables neurodegeneration.
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Supplementary Figure 1 | Overview of the meta-analysis. For simplicity, the
age-by-sex and AD-by-sex interaction analyses are not reported, but they were
performed using the same pipeline illustrated in this scheme.
Supplementary Figure 2 | Manhattan plots of sDMPs in the four brain regions.
The figure displays the Manhattan plots resulting from the meta-analysis of
sex-associated probes in FC (A), TC (B), ERC (C), and CRB (D). Significant
sDMPs are marked with dark color. Scale change across 50 is indicated by an
axis break.
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Supplementary Figure 3 | Manhattan plots of aDMPs in the four brain regions.
The figure displays the Manhattan plots resulting from the meta-analysis of
age-associated probes in FC (A), TC (B), ERC (C), and CRB (D). Significant
aDMPs are marked with dark color. Scale change across 50 is indicated by an
axis break.
Supplementary Figure 4 | Manhattan plots of AD-DMPs in the four brain
regions. The figure displays the Manhattan plots resulting from the meta-analysis
of AD-associated probes in FC (A), TC (B), ERC (C), and CRB (D). Significant
AD-DMPs are marked with dark color.
Supplementary Figure 5 | Confirmation of sDMPs and aDMPs in AD patients.
The scatter plots report, for the sDMPs and aDMPs identified in each tissue in
healthy subjects, the effect sizes obtained in healthy subjects against the effect
sizes resulting from the meta-analysis in AD patients. Pearson Correlation
coefficient is reported in each plot.
Supplementary Figure 6 | Contribution of 5hmC to the epigenetic changes
across sex, age, and AD. Correlation plots of the effect sizes of sDMPs, aDMPs,
and AD-DMPs identified in ERC and CRB, calculated using BS values
(5mC+5hmC), oxBS values (5mC), BS-oxBS values (5hmC), and 1-BS values
(5uC). Absolute correlation values are reported.
Supplementary File 1 | Significant sDMPs in the four brain regions. The tables
report the lists of sDMPs for each brain region (FC, TC, ERC, and CRB). Probes
resulting from the analysis of cross-region and region-specific sDMPs are
indicated by a cross, together with the probes that are in common with aDMPs or
AD-DMPs found in the same region.
Supplementary File 2 | Enrichment analysis of sDMPs. The tables report: (1) the
results of Fisher’s test on genomic distribution of sDMPs for each brain region,
considering genomic context and chromosomal location. Significant results
(p-value <0.05) are colored in green or red if depleted or enriched, respectively. (2)
the results of GO pathway enrichment analysis, after REViGO filtering. Only the
significant results (adjusted p-value <0.01) for each brain region are reported.
Supplementary File 3 | Significant aDMPs in the four brain regions. The tables
report the lists of aDMPs for each brain region (FC, TC, ERC, and CRB). Probes
resulting from the analysis of cross-region and region-specific sDMPs are
indicated by a cross, together with the probes that are in common with sDMPs or
AD-DMPs found in the same region.
Supplementary File 4 | Enrichment analysis of aDMPs. The tables report: (1) the
results of Fisher’s test on genomic distribution of aDMPs for each brain region,
considering genomic context and chromosomal location. Significant results
(p-value <0.05) are colored in green or red if depleted or enriched, respectively. (2)
the results of GO pathway enrichment analysis, after REViGO filtering. Only the
significant results (adjusted p-value <0.01) for each brain region are reported.
Supplementary File 5 | Probes with significant age-by-sex interaction in the four
brain regions. The tables report the lists of probes with significant age-by-sex
interaction in each brain region (FC, TC, ERC, and CRB).
Supplementary File 6 | Significant AD-DMPs in the four brain regions. The tables
report the lists of AD-DMPs for each brain region (FC, TC, ERC, and CRB). Probes
resulting from the analysis of cross-region and region-specific AD-DMPs are
indicated by a cross, together with the probes that are in common with sDMPs or
aDMPs found in the same region. The sheet “Sex Chromosomes” reports the
significant AD-DMPs identified on sex chromosomes when analyzing males and
females separately.
Supplementary File 7 | Enrichment analysis of AD-DMPs. The tables report: (1)
the results of Fisher’s test on genomic distribution of AD-DMPs for each brain
region, considering genomic context and chromosomal location. Significant results
(p-value <0.05) are colored in green or red if depleted or enriched, respectively. (2)
The results of GO pathway enrichment analysis, after REViGO filtering. Only the
significant results (adjusted p-value <0.01) for each brain region are reported.
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